Jan Jobsen
7PUBLICATIONS
39CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Oct 07, 2024
Clinical and Molecular Characteristics of High-Risk, Recurrent, or Metastatic Endometrial Cancer That Is Human Epidermal Growth Factor Receptor 2-Low.Dione van Dijk, Lisa Vermij, Alicia León-Castillo
|Sep 29, 2023
Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas.Amy Jamieson, Lisa Vermij, Claire J H Kramer
|Jul 24, 2023
Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer.Nanda Horeweg, Remi A Nout, Ina M Jürgenliemk-Schulz
|May 25, 2023
<i>QPOLE</i>: A Quick, Simple, and Cheap Alternative for <i>POLE</i> Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain Reaction.Anne Sophie V M Van den Heerik, Natalja T Ter Haar, Lisa Vermij
|Jan 23, 2023
Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry.Lisa Vermij, Jan J Jobsen, Alicia León-Castillo
|Aug 08, 2022
The clinical relevance of various methods of classifying ipsilateral breast tumour recurrence as either true local recurrence or new primary.Jan J Jobsen, Henk Struikmans, Ester Siemerink
Pageof 2
Frequent Collaborators
5 joint publications
Carien L Creutzberg
5 joint publications
Tjalling Bosse
4 joint publications
Lisa Vermij
4 joint publications
Nanda Horeweg
3 joint publications
Marie A D Haverkort
3 joint publications
Ludy Lutgens
2 joint publications
Jan Willem Mens
2 joint publications
C Blake Gilks
1 joint publications
Emma J Crosbie
1 joint publications
Hans W Nijman
